Parkinson's Disease clinical trials in Abington, PA

1 recruiting parkinson's disease studies with a site in Abington, PA.

All trials in Abington, PA · All Parkinson's Disease trials

RecruitingPhase 3NCT06989112

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Sponsor: AstraZeneca

Abington, PA · Hershey, PA · Philadelphia, PA · +60 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.